Table of Contents:

1 Report Prologue
2 Market Introduction
2.1 Introduction
2.2 Scope of Study
2.3 Research Objective
2.4 Assumptions & Limitations
2.4.1 Assumptions
2.4.2 Limitations
2.5 Market Structure
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Growing Incidence Number of Contagious and Non-Contagious Diseases
4.2.2 Improving Medical Device Regulation
4.2.3 Increasing Inclination Towards Home Healthcare
4.2.4 Increasing Prevalence of Diabetes
4.3 Restraint
4.3.1 Risk Associated with blood transfusion
5 Market Factor Analysis
5.1 Porter's Five Forces Model
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Supply Chain Analysis
6 Global Safety Lancet Market, By Type
6.1 Introduction
6.2 Push Button Safety Lancet
6.3 Pressure Activated Safety Lancet
6.4 Side Button Safety Lancet
7 Global Safety Lancet Market, By End User
7.1 Introduction
7.2 Hospitals & Clinics
7.3 Diagnostic Centers and Pathology Laboratories
7.4 Home Diagnostics
7.5 Other End Users
8 Global Safety Lancet Market, By Region
8.1 Introduction
8.2 North America
8.2.1 The U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 France
8.3.3 UK
8.3.4 Italy
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia-Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Republic of Korea
8.4.5 Rest of Asia-Pacific
8.5 Middle East & Africa
8.5.1 UAE
8.5.2 Egypt
8.5.3 Saudi Arabia
8.5.4 Rest of Middle East & Africa
9 Competitive Landscape
9.1 Pricing of Lancets
10 Company Profile
10.1 F. Hoffmann-La Roche AG
10.1.1 Overview
10.1.2 Product/Business Segment Overview
10.1.3 Financial Updates
10.1.4 Key Developments
10.1.5 SWOT Analysis
10.2 Becton, Dickinson and Company
10.2.1 Overview
10.2.2 Product/Business Segment Overview
10.2.3 Financial Updates
10.2.4 Key Developments
10.2.5 SWOT Analysis
10.3 Terumo Medical Corporation
10.3.1 Overview
10.3.2 Product/Business Segment Overview
10.3.3 Financial Updates
10.3.4 Key Developments
10.3.5 SWOT Analysis
10.4 Bayer AG
10.4.1 Overview
10.4.2 Product/Business Segment Overview
10.4.3 Financial Updates
10.4.4 Key Developments
10.4.5 SWOT Analysis
10.5 HTL-STREFA S.A.
10.5.1 Company Overview
10.5.2 Product/Business Segment Overview
10.5.3 Financial Updates
10.5.4 Key Development
10.5.5 SWOT Analysis
10.6 Sarstedt AG & Co.
10.6.1 Overview
10.6.2 Product/Business Segment Overview
10.6.3 Financial Overview
10.6.4 SWOT Analysis
10.7 Improve Medical Technology Co. Ltd
10.7.1 Overview
10.7.2 Product/Business Segment Overview
10.7.3 Financial Updates
10.7.4 SWOT Analysis